Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Laboratorio Reig Jofre SA

RJF.MC ✗ NOT COMPLIANT ☆ Track — members

BME · Healthcare · Pharmaceuticals ·

Spain Micro Cap Analyst: N/A

Last Close

$3.14

▲ +1.13%

Market Cap $260.37M · Vol 2.71K

Key Metrics

P/E Ratio

33.41

FWD: 22.42

Market Cap

$260.37M

Micro Cap

Div Yield

0.90%

Annual dividend

EPS Growth

+99.51%

YoY

RSI (14)

36.36

Momentum

Beta

0.84

vs Market

52W High

$3.88

19.21% below

52W Low

$2.69

19.15% above

Volume

2.71K

Avg 7.11K

P/B

0.96

Price-to-book

ROE

2.32%

Return on equity

Free Float

20.77%

Public shares

Shariah Compliance8 STANDARDS

✗ Laboratorio Reig Jofre SA (RJF.MC) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RJF.MC pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.75%

+1.13%

-2.54%

+4.37%

YTD

+5.59%

-7.39%

+21.70%

-42.47%

Financials & Valuation

TTM · Annual

Total Revenue	$388.87M
Net Income	$5.87M
Revenue Growth (YoY)	+0.63%
Gross Margin	54.34%
Operating Margin	1.82%
Net Profit Margin	1.51%
ROE	2.32%
ROA · ROIC	1.71% · 2.09%

P/E Ratio	33.41
Forward P/E (FY1)	22.42
PEG Ratio	-0.81
P/S	0.63
P/B	0.96
P/FCF	N/A
EPS Growth	+99.51%
Outstanding Shares	82.88M

Technical Indicators

50-Day SMA	$3.12
200-Day SMA	$3.09
RSI (14)	36.36
Beta	0.84
52-Week High	$3.88
52-Week Low	$2.69

Volume Today	2.71K
Avg Daily Volume (30D)	7.11K
Relative Volume	0.38x
Volatility (10D)	9.06
Volatility (30D)	15.92
Free Float	20.77%

Analyst Consensus

N/A

Current Price $3.14

Mean Target N/A

52W Low$2.69 52W High$3.88

Current

Target

$2.69 $3.88

Current Analyst target

· 2 analysts

Identifiers

ExchangeBME

FIGIBBG001SL71G3

ISINES0165359029

CountrySpain

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 13, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co +0.88% JNJ Johnson & Johnson +1.07% ABBV Abbvie Inc +1.20% NVS Novartis AG +1.68% NOVN.S Novartis AG +0.85%

Company Profile

Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.